Bychkov, Evgeny <br/><br/>
Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum.  [electronic resource] 

 -  Journal of neurochemistry  Aug 2007 
 - 699-711 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0022-3042 
<br/><br/><label>Standard No.: </label>10.1111/j.1471-4159.2007.04586.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Corpus Striatum--drug effects<br/>Dopamine--deficiency<br/>Dopamine Agents--pharmacology<br/>Dopamine Agonists--pharmacology<br/>Enzyme Activation--drug effects<br/>Glycogen Synthase Kinase 3--drug effects<br/>Glycogen Synthase Kinase 3 beta<br/>Levodopa--pharmacology<br/>Mitogen-Activated Protein Kinase 1--drug effects<br/>Opioid Peptides--drug effects<br/>Oxidopamine<br/>Parkinson Disease--drug therapy<br/>Pergolide--pharmacology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D3--drug effects<br/>Signal Transduction--drug effects<br/>Up-Regulation--drug effects